Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients.
Wesner N, Uruha A, Suzuki S, Mariampillai K, Granger B, Champtiaux N, Rigolet A, Schoindre Y, Lejeune S, Guillaume-Jugnot P, Vautier M, Hervier B, Simon A, Granier F, Gallay L, Nishino I, Benveniste O, Allenbach Y. Wesner N, et al. Among authors: rigolet a. Autoimmun Rev. 2020 Mar;19(3):102465. doi: 10.1016/j.autrev.2020.102465. Epub 2020 Jan 7. Autoimmun Rev. 2020. PMID: 31918028 No abstract available.
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Herson S, Hentati F, Rigolet A, Behin A, Romero NB, Leturcq F, Laforêt P, Maisonobe T, Amouri R, Haddad H, Audit M, Montus M, Masurier C, Gjata B, Georger C, Cheraï M, Carlier P, Hogrel JY, Herson A, Allenbach Y, Lemoine FM, Klatzmann D, Sweeney HL, Mulligan RC, Eymard B, Caizergues D, Voït T, Benveniste O. Herson S, et al. Among authors: rigolet a. Brain. 2012 Feb;135(Pt 2):483-92. doi: 10.1093/brain/awr342. Epub 2012 Jan 11. Brain. 2012. PMID: 22240777 Clinical Trial.
Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O. Stanciu R, et al. Among authors: rigolet a. J Rheumatol. 2012 Sep;39(9):1835-9. doi: 10.3899/jrheum.111604. Epub 2012 Aug 1. J Rheumatol. 2012. PMID: 22859355
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.
Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J, Servais L, Fain O, Larroche C, Diot E, Terrier B, De Paz R, Dossier A, Menard D, Morati C, Roux M, Ferrer X, Martinet J, Besnard S, Bellance R, Cacoub P, Arnaud L, Grosbois B, Herson S, Boyer O, Benveniste O; French Myositis Network. Allenbach Y, et al. Among authors: rigolet a. Medicine (Baltimore). 2014 May;93(3):150-157. doi: 10.1097/MD.0000000000000028. Medicine (Baltimore). 2014. PMID: 24797170 Free PMC article.
Severe adult dermatomyositis with unusual calcinosis.
Garel B, Barète S, Rigolet A, Le Pelletier F, Benveniste O, Hervier B. Garel B, et al. Among authors: rigolet a. Rheumatology (Oxford). 2015 Nov;54(11):2024. doi: 10.1093/rheumatology/kev287. Epub 2015 Aug 18. Rheumatology (Oxford). 2015. PMID: 26286744 No abstract available.
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.
Allenbach Y, Guiguet M, Rigolet A, Marie I, Hachulla E, Drouot L, Jouen F, Jacquot S, Mariampillai K, Musset L, Grenier P, Devilliers H, Hij A, Boyer O, Herson S, Benveniste O. Allenbach Y, et al. Among authors: rigolet a. PLoS One. 2015 Nov 5;10(11):e0133702. doi: 10.1371/journal.pone.0133702. eCollection 2015. PLoS One. 2015. PMID: 26539981 Free PMC article. Clinical Trial.
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.
Allenbach Y, Leroux G, Suárez-Calvet X, Preusse C, Gallardo E, Hervier B, Rigolet A, Hie M, Pehl D, Limal N, Hufnagl P, Zerbe N, Meyer A, Aouizerate J, Uzunhan Y, Maisonobe T, Goebel HH, Benveniste O, Stenzel W; French Myositis Network. Allenbach Y, et al. Among authors: rigolet a. Am J Pathol. 2016 Mar;186(3):691-700. doi: 10.1016/j.ajpath.2015.11.010. Epub 2016 Jan 21. Am J Pathol. 2016. PMID: 26806087 Free article.
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, Schoindre Y, Rigolet A, Gilardin L, Musset L, Charuel JL, Boyer O, Jouen F, Drouot L, Martinet J, Stojkovic T, Eymard B, Laforêt P, Behin A, Salort-Campana E, Fain O, Meyer A, Schleinitz N, Mariampillai K, Grados A, Benveniste O. Allenbach Y, et al. Among authors: rigolet a. Brain. 2016 Aug;139(Pt 8):2131-5. doi: 10.1093/brain/aww054. Epub 2016 Apr 17. Brain. 2016. PMID: 27086869
70 results